Open Targets
@opentargets.org
600 followers 38 following 170 posts
Public-private partnership using human genetics and genomics data for systematic drug target identification and prioritisation. http://blog.opentargets.org
Posts Media Videos Starter Packs
opentargets.org
CLOSING: Postdoc in @francescoiorio.bsky.social's lab at @humantechnopole.bsky.social

Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...

#scienceJobs #AcademicSky #postdocJobs
Closing job ad for a postdoc in CRISPR meta-analytics and AI, from Open Targets and the Human Technopole. The role is in the Iorio Lab, salary up to 40k euros, apply by 5 October.

The description reads: The Perturbation Catalogue project aims to create an online repository of data from post-perturbational experiments. You will focus on a meta-analytics project, developing computational methods for the reproducibility assessment, harmonisation and analysis or inter-study CRISPR datasets, aggregating data and developing and using innovative AI-based methods for therapeutic target prioritisation pipelines.
opentargets.org
USP18 is a negative regulator of interferon response, which suggests that the variant increases SLE risk by affecting USP18’s ability to limit the interferon response

Congratulations to the team on this work!
opentargets.org
They found an interesting variant in the USP18 locus: a trans-eQTL that increases the expression of 50 interferon response genes. This variant also colocalises with a GWAS signal for systemic lupus erythematosus (SLE)
Reposted by Open Targets
jengreitz.bsky.social
Excited for a major milestone in our efforts to map enhancers and interpret variants in the human genome:

The E2G Portal! e2g.stanford.edu

This collates our predictions of enhancer-gene regulatory interactions across >1,600 cell types and tissues.

Uses cases 👇

1/
opentargets.org
This release also features:

➡️ molQTL credible sets for targets
➡️ new options for the variant structural viewer
➡️ data updates from GWAS Catalog, Expression Atlas, gnomAD, DepMap, and Probes&Drugs

What do you think of this update?
opentargets.org
@riyavsinha.bsky.social @jengreitz.bsky.social sky.social @anshulkundaje.bsky.social y.social have made the ENCODE-rE2G data available to browse through the E2G portal, a custom-built extension of the Platform 👇

We plan to further integrate their data 👀

e2g.stanford.edu
E2G
E2G is a tool based on the Open Targets Platform for predicting enhancer-gene interactions.
e2g.stanford.edu
opentargets.org
This new data can provide insights about the function of genetic variants by linking them to likely regulatory elements that affect the transcriptional activity of nearby genes, and is available to browse on our variant pages
An example of an intervals widget for a variant in the Open Targets Platform
opentargets.org
The Open Targets Platform autumn release is out! 🍂

We have ingested the full dataset of over 13 million enhancer-gene regulatory interactions in the human genome across 1,458 DNase-seq experiments covering 369 cell types and tissues from the ENCODE-rE2G model

blog.opentargets.org/open-targets...
Open Targets Platform 25.09 has been released!
The September 25 release includes enhancer-gene data predicted by ENCODE-rE2G, molQTL credible sets for targets, new options for the variant structural viewer, and a number of data updates from GWAS C...
blog.opentargets.org
opentargets.org
This is fantastic — congratulations @gwascatalog.bsky.social!
Reposted by Open Targets
gwascatalog.bsky.social
🚩1 MILLION curated associations!!! 🚩
Launched in 2008, took us 15 years to reach 500K, and thanks to your research and collaboration, we doubled the number in less than 3 years!
See some data insights tinyurl.com/mw53njbb
#OpenAccess
opentargets.org
Last call to submit a project for the Open Targets Hackathon!

Submit a project by 12 September: docs.google.com/forms/d/e/1F...

We will prioritise projects where the project leads have signed up to attend the hackathon. Registrations are currently full but you can sign up to the waiting list
Open Targets Hackathon: one week left to submit a project
opentargets.org
The authors suggest that small molecule inhibition of LRRK2, or reduction in LRRK2 protein levels, may help slow the progression of diseases involving tau or alpha-synuclein, such as Alzheimer’s and Parkinson’s disease.

Congratulations to the whole team for this work! 🎉
opentargets.org
The study revealed that LRRK2 was required for the uptake of tau and alpha-synuclein, and that the LRRK2 Parkinson’s disease gain-of-function mutation increases the uptake of both forms of tau and alpha-synuclein.
opentargets.org
They found that monomeric and fibrillar tau are taken up by neurons in overlapping but distinct pathways.
opentargets.org
Using genome-wide CRISPR knockout screens, the team delineate the genes required for extracellular uptake of monomeric and fibrillar tau in human iPSC-derived excitatory neurons, the primary cell type affected in tauopathies.
opentargets.org
Several neurodegenerative diseases are characterised by the formation fibrils of misfolded tau protein, and it is thought that disease progresses through the central nervous system from affected neurons releasing pathogenic forms of tau protein, which are then taken up by neighbouring neurons.
opentargets.org
Google Cloud is sponsoring the compute for the Open Targets hackathon!

There is now a waiting list to attend the event in person, but project submissions and online registrations are still open.

The two-day hackathon will explore data, analyses, and tools for target discovery
Text reads: Open Targets hackathon, 21-22 October 2025, compute sponsored by Google Cloud
opentargets.org
Thank you!

Do you have more questions for Carlos?